TP-271

DRUG4 trials

Sponsors

Tetraphase Pharmaceuticals, Inc

Conditions

Bacterial InfectionsPneumonia

Phase 1

A Phase 1 Study to Assess the Safety, Tolerability and PK of IV TP-271

CompletedNCT02724085

Tetraphase Pharmaceuticals, IncPneumonia

Start: 2015-12-18End: 2016-12-12Updated: 2021-12-13

A Phase 1 TP-271 Oral PK Single Ascending Dose Study

CompletedNCT03024034

Tetraphase Pharmaceuticals, IncBacterial Infections

Start: 2017-03-02End: 2018-06-04Updated: 2021-12-13

A Phase 1 Safety and PK Study of IV TP-271

CompletedNCT03234738

Tetraphase Pharmaceuticals, IncBacterial Infections

Start: 2017-08-16End: 2018-01-02Updated: 2021-12-13

A Phase 1 TP-271 Oral PK Multiple Ascending Dose Study

CompletedNCT03450187

Tetraphase Pharmaceuticals, IncBacterial Infections

Start: 2018-03-20End: 2019-03-31Updated: 2021-12-17